EDX Medical Group’s Post

The LSI Alumni Q1 2024 Funding Update is out now! 💸 In Q1 of 2024, over $420 million was raised by the #LSIAlumni across 25+ deals. 🌟 View our spreadsheet with all the details from Q1: https://lnkd.in/gzSb_tKX 📌 Here’s a sneak peak at a few LSI Alumni deals from the spreadsheet: • Acorai // $4.5M Seed Round • Vektor Medical, Inc. // $16M Series A • Argá Medtech SA // $58.6M Series B • Onera Health // $32.7M Series C • Phagenesis Ltd // $42M Series D To learn more about LSI’s market intelligence software and services, the markets we cover and how we support the biggest strategic decision making for our partners (like Medtronic and McKinsey & Company) don’t hesitate to reach out to our team. Check out the spreadsheet linked above to see all 25+ Q1 2023 Alumni deals for yourself (and the full 2023 & 2022 Funding Reports)👆

Are you joining us at Outsourcing in Clinical Trials Southern California? Make sure to drop by booth 33 and meet Liliane Nguyen and Adriano M. to discover how Cytel empowers life science leaders to realize the full potential of therapies! Book your meeting here: https://hubs.ly/Q02P5gsZ0 #OCT #Clinical Trials #Outsourcing

🚨 SPRING NEWSLETTER ALERT!!! 🚨 The Alliance for Artificial Intelligence in Healthcare (AAIH) has just released our 2024 Spring Newsletter!!! If you are signed up for our newsletter, make sure to check your inbox for something exciting! If you are not yet signed up for our newsletter, click the link below to join our email list, and read about all the exciting things AAIH members have been up to, and what is to come! https://conta.cc/3yGNr6K

What sets us apart is our deep understanding of the intricacies of regulations and the critical drivers behind clinical trial success. We don't just skim the surface; we dive deep into your world, unravelling the complexities to provide insights that go beyond the ordinary. Partner with us and unlock the full potential of your life science vision. Get started here: https://bit.ly/4d9tvZX #GoodlandPharma #TailoredExpertise #LifeSciences #ClinicalTrials

We're thrilled to present a panel discussion at Keiretsu Forum focusing on the latest MedTech and life sciences trends. Accredited investors, this is your chance to engage with industry insiders and gain valuable insights. #KeiretsuForum #VentureCapital #MedTechInnovation

Ready for day 2 of the Veeva Commercial Summit? Yesterday was filled with insightful discussions, groundbreaking innovations, and marvelous networking opportunities. And guess what? The excitement isn't over yet. We’re excited to continue the deep dive into the latest commercial and medical advancements in the life sciences industry. 💡 Are you attending the summit? Make sure to swing by our booth and say hi. Our team is here, ready to connect, collaborate, and share insights on how BASE life science can help you succeed. 💬 #VeevaSummit

Designing a clinical trials is no easy feat. Our CEO Shaherah Yancy is moderating a panel on the basics of designing, developing, and completing your clinical trials at Life Science Tennessee #LSTCON, and it's one of our core offerings at RLS. Click over to our website to learn how we can guide your #startup through your #clinicaltrial - at reasonable rates half that of most CROs.

What sets us apart is our deep understanding of the intricacies of regulations and the critical drivers behind clinical trial success. We don't just skim the surface; we dive deep into your world, unravelling the complexities to provide insights that go beyond the ordinary. Partner with us and unlock the full potential of your life science vision. Get started here: https://bit.ly/4d9tvZX #GoodlandPharma #TailoredExpertise #LifeSciences #ClinicalTrials

Join us on May 29th for a Panel Discussion: "Scaling to the Clinic: Strategies for evaluating the right lab resourcing solution for your R&D efforts." We're pleased to co-host this event with SmartLabs. RSVP via the link in the comments below. The panel will be moderated by US Lab Partners LLC Founder Demet Aybar and will feature panelists: Angela Hui, VP of Operations, Elektrofi John Maynes, Associate Director of Lab Operations, Prime Medicine, Inc. Christian Lawrence, Site Director, SmartLabs Michael Magliochetti, Operating Partner, Riverside Partners Brian Gallagher, Jr., Managing Partner and Co-Founder, Trekk Venture Partners Volatile conditions in the biopharma funding market and the rise of novel therapies make it imperative that a company’s operating strategies be managed in a way that successfully shepherd assets forward in a cost-efficient manner. For start-up companies with one or two assets, stretching runway to reach the next milestone is top of mind when satisfying investors and securing additional investment. Midsize and larger companies must also marshal resources strategically in their race to get assets into the clinic in a hypercompetitive research environment. Companies can choose to outsource, insource, or defer costs at every stage of R&D and across dozens of different workflows. During this interactive discussion, hear how leaders pursuing novel therapies are weighing their strategies for resourcing to support great science while meeting the practical and economic considerations of R&D. #biopharma #funding #R&D #operations #science

Patients are at the core of clinical trials, and designing studies with their needs in focus can be a win-win. In a recent article in pharmaphorum, TransCelerate’s Executive Director of Portfolio Management, Jeneen Donadeo, highlights how simplifying trial processes—like using patient-friendly language and offering flexible participation options—can have real impact. Read here: https://lnkd.in/e7RcxwqE